ICA continues to host meetings and keynote speeches online to help converge listed companies and investors and capture insights into the recent development trends in Asia’s healthcare arena.
ICA, an Asia-based leader in investor relations, financial communications, investor access, and IPO advisory, has announced that it will host the 2nd Annual Asia Pacific Healthcare Conference May 18-24, 2022.
This event will bring together healthcare leaders and industry professionals online to provide updates on the recent business development trends during the post-COVID-19 era. Around 30 healthcare enterprises will virtually interact with 100 global buy-side institutions, including global asset managers, insurance companies, multi-billion hedge funds, and boutique emerging market funds.
In addition to online meetings, there will be a few prestigious keynote speakers joining us to share insights from different perspectives, including:
- Gary Chiu, Head of Index Strategic Research, Hang Seng Indexes Company;
- Aaron Finley, South China Business Development Director, Deloitte China;
- Brad Loncar, CEO of Loncar Investment;
- Joshua Berlin and Jeff Cranmer of BioCentury
“Despite challenges brought by the pandemic, ICA is dedicated to constructing a platform to help connect Asia-based biotech companies with high-quality and influential investors worldwide,” said Kevin Yang, CEO and Founder of ICA. “We hope our conferences will help foster more dialogues between listed biotech companies and investors and illustrate a holistic picture for the global investment community.”
